| Ms Christina Kay Geers, RPH | |
|
113 E Broadway, Ashland, MO 65010-7700 | |
| (573) 657-2600 | |
| (573) 657-2927 |
| Full Name | Ms Christina Kay Geers |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 113 E Broadway, Ashland, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427305077 | NPI | - | NPPES |
| 603177007 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 041909 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Christina Kay Geers, RPH Po Box 348, 113 E Broadway, Ashland, MO 65010-0348 Ph: (573) 657-2600 | Ms Christina Kay Geers, RPH 113 E Broadway, Ashland, MO 65010-7700 Ph: (573) 657-2600 |
News Archive
A new study provides compelling evidence that a simple tool can help predict which patients with cancer may be in their final year of life. The tool, known as the Surprise Question, was found to predict the risk of cancer death within one year better than factors such as cancer type or stage alone. This study will be presented at the upcoming 2015 Palliative Care in Oncology Symposium in Boston.
Alzheimer's disease (AD) is a common problem that is becoming progressively burdensome throughout the world. A new supplement to the Journal of Alzheimer's Disease, Imaging the Alzheimer Brain, clearly shows that multiple imaging systems are now available to help understand, diagnose, and treat the disease.
Obese youths with particular genetic variants may be more prone to fatty liver disease, a leading cause of chronic liver disease in children and adolescents in industrialized countries, according to new findings by Yale School of Medicine researchers.
CRNS and the Institut Pasteur conducted research in France on patients diagnosed with cryptococcosis which ranks second among fatal opportunistic infections in patients infected by HIV and who are profoundly immunosuppressed.
Antisense Therapeutics Ltd. (ASX: ANP) has reported further positive results from its collaborative preclinical research studies on the therapeutic potential of ATL1101 in prostate cancer. In experimental models, ATL1101 treatment significantly enhanced the tumor-suppressive effect of the cancer drug Paclitaxel. Paclitaxel is one of a class of drugs known as taxanes.
› Verified 7 days ago
Dr. Jeanette Louise Quinn, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 603 Dogwood Ct, Ashland, MO 65010 Phone: 573-825-7780 | |
Molly Schooler, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 109b Eastside Dr, Ashland, MO 65010 Phone: 573-657-3333 Fax: 573-657-7022 |